Horm Metab Res 2002; 34(7): 414-415
DOI: 10.1055/s-2002-33476
Short Communication
© Georg Thieme Verlag Stuttgart · New York

No Sizable Inhibition of Glucose-Induced Insulin Secretion by Acarbose and Castanospermine

I.  Miwa 1 , K.  Shibata 1 , N.  Asano 2
  • 1Department of Pathobiochemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan
  • 2Department of Biochemistry, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan
Further Information

Publication History

Received: 23 January 2002

Accepted after revision: 18 March 2002

Publication Date:
21 August 2002 (online)

Introduction

Lundquist and co-workers proposed that one of the multiple signals implicated in glucose-induced insulin release is transduced through the vacuolar system involving the activation of lysosomal acid glucan-1,4-α-glucosidase [1] [2] [3] [4] [5] [6] [7]. In their view, this lysosomal enzyme attacks α-1,4-linked glucose polymers, such as glycogen, to produce high local concentrations of vacuolar glucose, which in turn might act as a metabolic, osmotic, or cybernetic messenger in insulin secretion. Their proposal was based on their findings of a close relationship between islet acid glucan-1,4-α-glucosidase activity and insulin secretion in a series of experiments with isolated islets, where 4 selective α-glucosidase inhibitors - miglitol [2], acarbose [3] [6] [7], emiglitol [4], and castanospermine [5] - suppressed glucose-induced insulin secretion in parallel with their inhibitory effect on islet glucan-1,4-α-glucosidase activity. No other investigators, however, have verified whether their proposal is valid or not. The aim of the present study was to assess the validity of their interesting view by examining the ability of acarbose and castanospermine to inhibit glucose-induced insulin secretion.

References

  • 1 Lundquist I. . Horm Metab Res 1972 4: 245-249
  • 2 Salehi A, Lundquist I. . Am J Physiol 1993 265: E1-E9
  • 3 Salehi A, Panagiotidis G, Borg L AH, Lundquist I. . Diabetes 1995 44: 830-836
  • 4 Lundquist I, Panagiotidis G, Salehi A. . Endocrinology 1996 137: 1219-1225
  • 5 Salehi A, Mosén H, Linell M, Lundquist I. . Pharmacol Rev Commun 1998 10: 165-173
  • 6 Salehi A, Henningsson R, Mosén H, Östenson C-G, Efendic S, Lundquist I. . Endocrinology 1999 140: 3045-3053
  • 7 Salehi A, Fan B-G, Ekelund M, Nordin G, Lundquist I. . Am J Physiol 2001 281: E171-E179
  • 8 Taniguchi S, Asano N, Tomino F, Miwa I. . Horm Metab Res 1998 30: 679-683
  • 9 Gunawardana S C, Sharp G WG. . Diabetes 2002 51: 105-113

Dr. I. Miwa

Department of Pathobiochemistry · Faculty of Pharmacy · Meijo University

150 Yagotoyama, Tenpaku-ku · Nagoya-shi, Aichi 468-8503 · Japan

    >